Product
somavaratan
1 clinical trial
1 indication
Indication
Adult Growth Hormone DeficiencyClinical trial
An Open-Label, Long-Term Extension Study of the Safety of Somavaratan (VRS-317) in Adults With Growth Hormone Deficiency (GHD)Status: Terminated, Estimated PCD: 2018-01-11